Rifampin isoniazid pyrazinamide how supplied

Rifampin Isoniazid Pyrazinamide
RIFATER ® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

How Supplied

RIFATER tablets are light beige, smooth, round, and shiny sugar-coated tablets imprinted with "RIFATER" in black ink and contain 120 mg rifampin, 50 mg isoniazid, and 300 mg pyrazinamide, and are supplied as:

Bottles of 60 tablets (NDC 0088-0576-41).

Storage

Store at 25°C (77°F); excursions permitted to 15–30°C (59–86°F) [see USP Controlled Room Temperature]. Protect from excessive humidity.

Reference

Clinical Laboratory Standards Institute. 2003. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Document M24-A.

Sanofi-Aventis U.S. LLC Bridgewater, NJ 08807 A SANOFI COMPANY

Revised February 2013

©2013 sanofi-aventis U.S. LLC

References

Adapted from the FDA Package Insert.